E-Tech Resources Director Chris Drysdale joins Natalie Stoberman from the Proactive studios to share how the company has expanded its footprint significantly by acquiring a license next to its Eureka project in Namibia.

Drysdale says this move has given the company access to previously unexplored areas and significantly increased its potential for mineralization. E-Tech has already identified 17 new drill targets and completed 1,300 metres of drilling in the fourth quarter of 2022. Drysdale adds the company plans to continue using advanced exploration methods to expand its knowledge and understanding of the geology and mineralization potential of the Eureka project and surrounding areas, and keep its shareholders and stakeholders updated with the progress.

#ProactiveInvestors #ETechResources #RareEarthElements #Namibia #EurekaProject #Exploration #Mineralisation #Investing #Mining #StockMarket #AdvancedExploration #Drilling #ResourceExpansion #Stakeholders #Shareholders #PotentialGrowth #NewsUpdate

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Xeris Biopharma Chairman & CEO Paul Edick joins Natalie Stoberman from the Proactive newsroom to share details behind its research evaluation collaboration with Regeneron Pharmaceuticals for further XeriJect development.

Edick says the agreement will have Xeris using its proprietary drug-formulation platform, XeriJect, to develop ultra-highly concentrated, ready-to-use, small volume subcutaneous injections of two undisclosed monoclonal antibodies developed by Regeneron.

Xeris will receive an upfront payment and potential milestone payments for preclinical achievements. Thus, Regeneron will have an option to commercially license the Xeris technology for such molecules and nominate additional molecules for reformulation and potential commercialization.

#proactiveinvestors #xerisbiopharma #Nasdaq #XERS #biopharma #biotech #xeriject #regeneronpharmaceuticals #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Algernon Pharmaceuticals CEO Christopher Moreau joined Steve Darling from Proactive to share news the company’s subsidiary Algernon Neuroscience has announced it has completed dosing of the second cohort in the Phase 1 clinical study of DMT.

Moreau telling Proactive this study is to identify the safety and tolerability of DMT when administered as an intravenous bolus followed by a prolonged infusion of 6 hours which has never been studied clinically.

#proactiveinvestors #algernonpharmaceuticals #cse #otcqb #ifenprodil #pharma

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Jump Start Sports Founder and CEO Rick Hart joined Steve Darling from Proactive to share news the company has completed the sale of its 4th and 5th franchise territories in Ohio. Those territories include Lorain, Huron and Erie and Sandusky counties, as well as areas west toward Toledo.

Hart telling Proactive more about the program and also about the parent company Bell Buckle and its season team.

#proactiveinvestors #bellbuckleholdingsinc #otc #bllb #sports #franchise

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

BioHarvest Sciences CEO Ilan Sobel joined Steve Darling from Proactive to share news the company will be launching a major media campaign to support its flagship supplement VINIA in the United States.

Sobel telling Proactive the campaign will use real VINIA users telling their ‘Real Stories” on television and social media. The science behind the product with also be highlighted. BioHarvest has set its 2023 guidance with plans to increase global VINIA® sales to over 17 million dollars.

#proactivinvestors #cse #bhsc #otcqb #cnvcf #pharma #biotech

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Kinetiko Energy Ltd (ASX:KKO, OTC:KKOEF) CEO Nick de Blocq tells Proactive the company has received funding from the Industrial Development Corporation of South Africa (IDC), for use in the development of gas fields for industrial, commercial, transportation or power generation applications. The proposed gas field comprises about 20 wells to produce gas and IDC has a first right to participate in up to 45% of the next 60 wells. The company already has approvals in place for the JV and field commencement which is expected to begin in late 2023.

#ProactiveInvestors #KinetikoEnergy #ASX #gas #SouthAfrica

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Golden Rim Resources Ltd (ASX:GMR, OTC:GMRMF) MD Tim Strong tells Proactive the company continues to identify shallow, broad gold zones during drilling at Bereko and Massan prospects within the Kada Gold Project in Guinea. Standout assays from RC drilling at Bereko include 9 metres at 2.8 g/t gold while at Massan assays include 56 metres at 1.7 g/t gold. Diamond drilling is also progressing and is expected to significantly improve understanding of the structural controls on mineralisation.

#ProactiveInvestors #GoldenRimResources #ASX #gold #Guinea

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Elementos Ltd (ASX:ELT) MD Joe David speaks with Proactive soon after completing a A$3 million placement to tick off some key milestones at its Oropesa Tin Project in Spain, including completion of a definitive feasibility study (DFS). Company directors strongly supported the capital raise, with chairman Andy Grieg subscribing for 26.67% or A$800,000 of shares. In total, directors subscribed for 4,805,556 shares or around A$865,000.

#ProactiveInvestors #ElementosLtd #ASX #tin #Oropesa

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Imugene Ltd (ASX:IMU) CEO Leslie Chong tells Proactive that the company has dosed the first patients in cohort three of its intravenous (IV) and intratumoral (IT) monotherapy dose-escalation trial for novel cancer-killing virus VAXINIA (also known as CF33-hNIS). The City of Hope-developed oncolytic virus has been shown to shrink colon, lung, breast, ovarian and pancreatic cancer tumours in preclinical laboratory and animal models.

#ProactiveInvestors #ImugeneLtd #ASX #biotech

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

NickelSearch Ltd (ASX:NIS) MD Nicole Duncan tells Proactive the company has identified multi-element potential at the Carlingup Project in Western Australia following an independent geochemical review of available soil data. The review identified five high-priority lithium-caesium-tantalum (LCT) pegmatite target areas, as well as four high-priority Volcanogenic Hosted Massive Sulphides (VHMS) targets prospective for base metals.

#ProactiveInvestors #NickelSearch #ASX #nickel #lithium #BaseMetals

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews